Pfizer, U.S.
Pfizer, U.S., researchers publish latest findings
Published in Medical Verdicts and Law Weekly, December 14th, 2006
This trend article about Pfizer, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New investigation results, "Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers," are detailed in a study published in Journal of Clinical Pharmacology. According to recent research from the United States, "Varenicline is a novel selective alpha4beta2 nicotinic acetylcholine partial agonist developed for smoking cessation. This study investigated the single-and multiple-dose pharmacokinetics, safety, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Business & Finance
AutoImmune reports loss of $0.00 per share - Business & Finance
Celesio records, as anticipated, weaker growth in third quarter - Business & Finance
Cellegy reports third quarter financial results - Business & Finance
Chembio Diagnostics announces 8% third quarter revenue increase over same period last year - Business & Finance
DOV Pharmaceutical announces net loss of $17.5 million in third quarter - Business Update
Amerigroup to file form 12b-25 notification of late filing - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
